NOVO NORDISK A S
Related Filers (15)
- ARADIGM CORP (13)
- BlackRock Inc. (9)
- Capital World Investors (7)
- FMR LLC (6)
- CAPITAL RESEARCH & MANAGEMENT CO (6)
- Affimed N.V. (5)
- Dicerna Pharmaceuticals Inc (5)
- Forma Therapeutics Holdings, Inc. (5)
- ZYMOGENETICS INC (4)
- JPMorgan Chase Bank, N.A. - ADR Depositary (4)
- EUROPACIFIC GROWTH FUND (2)
- PIERIS PHARMACEUTICALS, INC. (2)
- Capital Research Global Investors (1)
- Strongbridge Biopharma plc (1)
- Innate Pharma SA (1)
- Show More ...
Other (1738)
6-K
Wednesday, 2/14/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/13/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 2/12/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/9/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/7/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/6/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 2/5/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/2/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/31/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 1/31/2024
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
IRANNOTICE
Wednesday, 1/31/2024
Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
6-K
Wednesday, 1/31/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/30/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/22/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/16/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/11/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/8/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/8/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/19/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 12/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Friday, 11/24/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Tuesday, 11/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Thursday, 11/9/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Tuesday, 11/7/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/7/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Friday, 10/20/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Monday, 10/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Friday, 9/29/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Tuesday, 9/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Wednesday, 9/13/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Wednesday, 9/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Wednesday, 9/13/2023
Notice of Effectiveness
CORRESP
Tuesday, 9/5/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Tuesday, 9/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-6
Thursday, 8/31/2023
Registration statement for American Depositary Receipts representing securities of certain foreign private issuers
6-K
Monday, 8/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/18/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/31/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
11-K
Tuesday, 6/27/2023
Annual report of employee stock purchase, savings and similar plans
11-K
Tuesday, 6/27/2023
Annual report of employee stock purchase, savings and similar plans
6-K
Monday, 6/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
SD
Tuesday, 5/23/2023
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
6-K
Tuesday, 5/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/16/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/4/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/7/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Ownership (57)
SC 13G/A
Tuesday, 2/6/2024
BlackRock Inc.: Major Shareholders
SC 13G/A
Thursday, 2/23/2023
BlackRock Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/1/2022
BlackRock Inc.: Major Shareholders
SC 13G/A
Friday, 1/29/2021
BlackRock Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/5/2020
BlackRock Inc.: Major Shareholders
SC 13G
Monday, 2/3/2020
Innate Pharma SA: Major Shareholders
SC 13G/A
Wednesday, 2/6/2019
BlackRock Inc.: Major Shareholders
SC 13G/A
Friday, 1/25/2019
Affimed N.V.: Major Shareholders
SC 13G
Friday, 12/21/2018
Strongbridge Biopharma plc: Major Shareholders
SC 13G/A
Thursday, 2/8/2018
Affimed N.V.: Major Shareholders
SC 13G
Thursday, 2/1/2018
BlackRock Inc.: Major Shareholders
SC 13G/A
Wednesday, 1/25/2017
PIERIS PHARMACEUTICALS, INC.: Major Shareholders
SC 13G/A
Friday, 9/9/2016
BlackRock Inc.: Major Shareholders
SC 13G/A
Thursday, 6/16/2016
Affimed N.V.: Major Shareholders
SC 13G
Tuesday, 2/9/2016
BlackRock Inc.: Major Shareholders
SC 13G
Thursday, 1/28/2016
PIERIS PHARMACEUTICALS, INC.: Major Shareholders
SC 13G
Tuesday, 2/17/2015
Affimed N.V.: Major Shareholders
SC 13D
Monday, 9/22/2014
Affimed N.V.: Major Shareholders
SC 13G/A
Thursday, 2/13/2014
EUROPACIFIC GROWTH FUND: Major Shareholders
SC 13G/A
Thursday, 2/13/2014
Capital World Investors: Major Shareholders
SC 13G
Wednesday, 2/13/2013
EUROPACIFIC GROWTH FUND: Major Shareholders
SC 13G/A
Wednesday, 2/13/2013
Capital World Investors: Major Shareholders
SC 13G/A
Tuesday, 2/14/2012
FMR LLC: Major Shareholders
SC 13G/A
Friday, 2/10/2012
Capital World Investors: Major Shareholders
SC 13G/A
Monday, 2/14/2011
FMR LLC: Major Shareholders
SC 13G/A
Monday, 2/14/2011
Capital World Investors: Major Shareholders
4
Tuesday, 11/9/2010
ARADIGM CORP: Statement of changes in beneficial ownership of securities
4
Friday, 11/5/2010
ARADIGM CORP: Statement of changes in beneficial ownership of securities
4
Thursday, 11/4/2010
ARADIGM CORP: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/3/2010
ARADIGM CORP: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/2/2010
ARADIGM CORP: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/12/2010
ZYMOGENETICS INC: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 10/12/2010
ZYMOGENETICS INC: Major Shareholders
SC 13D/A
Thursday, 9/16/2010
ARADIGM CORP: Major Shareholders
4
Thursday, 9/16/2010
ARADIGM CORP: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 2/16/2010
FMR LLC: Major Shareholders
SC 13G/A
Thursday, 2/11/2010
Capital World Investors: Major Shareholders
4
Monday, 1/11/2010
ZYMOGENETICS INC: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 1/8/2010
ZYMOGENETICS INC: Major Shareholders
SC 13G/A
Thursday, 2/12/2009
Capital World Investors: Major Shareholders
SC 13G/A
Wednesday, 2/13/2008
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G
Monday, 2/11/2008
Capital Research Global Investors: Major Shareholders
SC 13G
Monday, 2/11/2008
Capital World Investors: Major Shareholders
SC 13G/A
Monday, 12/10/2007
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Monday, 2/12/2007
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Friday, 9/8/2006
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Friday, 2/10/2006
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G
Thursday, 11/10/2005
CAPITAL RESEARCH & MANAGEMENT CO: Major Shareholders
SC 13G/A
Tuesday, 10/11/2005
FMR CORP: Major Shareholders
SC 13G/A
Monday, 2/14/2005
FMR CORP: Major Shareholders
SC 13D/A
Wednesday, 9/29/2004
ARADIGM CORP: Major Shareholders
SC 13G
Tuesday, 2/17/2004
FMR CORP: Major Shareholders
SC 13D/A
Friday, 3/14/2003
ARADIGM CORP: Major Shareholders
SC 13D/A
Friday, 2/28/2003
ARADIGM CORP: Major Shareholders
SC 13D/A
Thursday, 8/8/2002
ARADIGM CORP: Major Shareholders
4
Thursday, 8/8/2002
ARADIGM CORP: Statement of changes in beneficial ownership of securities
SC 13D
Wednesday, 11/14/2001
ARADIGM CORP: Major Shareholders
Prospectus (17)
SC TO-T/A
Friday, 10/14/2022
Third party tender offer statement
SC TO-T/A
Friday, 10/7/2022
Third party tender offer statement
SC TO-T/A
Wednesday, 9/28/2022
Third party tender offer statement
SC TO-T
Thursday, 9/15/2022
Third party tender offer statement
SC TO-C
Thursday, 9/1/2022
Written communication relating to an issuer or third party tender offer
S-8
Thursday, 3/24/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SC TO-T/A
Tuesday, 12/28/2021
Third party tender offer statement
SC TO-T/A
Monday, 12/27/2021
Third party tender offer statement
SC TO-T/A
Wednesday, 12/8/2021
Third party tender offer statement
SC TO-T
Wednesday, 11/24/2021
Third party tender offer statement
SC TO-C
Thursday, 11/18/2021
Written communication relating to an issuer or third party tender offer
S-8
Thursday, 2/8/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Tuesday, 10/31/2017
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8 POS
Thursday, 2/12/2009
Post-effective amendment to a S-8 registration statement
S-8 POS
Thursday, 11/6/2008
Post-effective amendment to a S-8 registration statement
S-8
Friday, 3/1/2002
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Thursday, 2/7/2002
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans